A Goel, A Ray, A Chavan, S Sahni, B K Gupta, S K Raut, S Agarwal, J Nehra, B Somu, R Ragu, Aakansha, C Nagpal, C Rajanna, A Shahi, R Anand, A Varadrajan, I Hasan, P Choppala, M Priyadarshi, D Jain, S Arulselvi, S Arava, G Singh, P Das, C Sarkar, N Nischal, M Soneja, P Jorwal, A Trikha, N Wig
INTRODUCTION: COVID-19 causes morbid pathological changes in different organs including lungs, kidneys, liver, etc., especially in those who succumb. Though clinical outcomes in those with comorbidities are known to be different from those without - not much is known about the differences at the histopathological level. AIMS: To compare the morbid histopathological changes in COVID-19 patients between those who were immunocompromised (Gr 1), malignancy (Gr 2), or had cardiometabolic conditions (hypertension, diabetes, or coronary artery disease) (Gr 3)...
December 8, 2022: Journal of Medical Virology